Currently, both the National Comprehensive Cancer Network (NCCN) guidelines and European Society for Medical Oncology (ESMO) guidelines recommend genetic testing for BRCA1 and BRCA2 for women with multiple primary breast cancers, if first diagnosis was ≤50 years old [17,18]. This evidence concerns the gene BRCA2 and breast cancer.